Health ❯ Healthcare

Regulatory Agencies

FDA Anvisa MHRA European Medicines Agency Food and Drug Administration Drug Approval Process ANSM Drug Safety Drug Approval ANMAT

UK Clears Aficamten (MYQORZO) for Symptomatic Obstructive Hypertrophic Cardiomyopathy

NICE recommendation and a confidential NHS discount mean about 6,600 eligible adults could start the once‑daily pill within weeks.

More Than 2.5 Million Lupin Eye Drop Bottles Recalled Nationwide

MHRA Warns Heat Can Damage Medicines and Medical Devices

EMA Committee Recommends Revoking Tavneos Authorization

Anvisa Approves Inluriyo as Oral Treatment for ER‑Positive, HER2‑Negative, ESR1‑Mutant Advanced Breast Cancer

Anvisa Approves First Non‑Hormonal Drug for Menopausal Hot Flashes

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

Six Victorians Suffer Acute Liver Toxicity After Using Illegal Peptide Labelled Retatrutide

Thousands Face Complex Surgery After M6‑C Neck Disc Is Linked to Bone Loss

FDA Approves First Generic Single‑Dose Flu Drug

Anvisa Orders Recall of Three Injectable Drug Lots After Contamination and Quality Failures

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

Anvisa Orders Seizure of Falsified Growth Hormone and Stolen Cancer Drug

Anvisa Orders Recall of Unregistered Infant Formula From Santa Catarina Compounding Pharmacy

FDA Launches Retrospective Safety Study of Mifepristone

Brazil Medical Council Bans Doctors From Using Injectable PMMA

Brazil Clears First Domestic Semaglutide Pen and Sets Price Ceiling Equal to Ozempic

MHRA Recalls Batch of Ramipril 2.5mg After Packaging Error

Mexico Issues Alert After Falsified Ozempic Lot Identified

Anvisa Registers Ozivy as Brazil’s First Synthetic Semaglutide Analogue